Detalhe da pesquisa
1.
Comparison of metabolic and immunologic responses to transarterial chemoembolization with different chemoembolic regimens in a rabbit VX2 liver tumor model.
Eur Radiol
; 32(4): 2437-2447, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34718844
2.
Idarubicin-Loaded ONCOZENE Drug-Eluting Bead Chemoembolization in a Rabbit Liver Tumor Model: Investigating Safety, Therapeutic Efficacy, and Effects on Tumor Microenvironment.
J Vasc Interv Radiol
; 31(10): 1706-1716.e1, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32684417
3.
Analysis of Tumor Burden as a Biomarker for Patient Survival with Neuroendocrine Tumor Liver Metastases Undergoing Intra-Arterial Therapies: A Single-Center Retrospective Analysis.
Cardiovasc Intervent Radiol
; 45(10): 1494-1502, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35941241
4.
Lipiodol Deposition and Washout in Primary and Metastatic Liver Tumors After Chemoembolization.
In Vivo
; 35(6): 3261-3270, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34697157
5.
Lipiodol as an intra-procedural imaging biomarker for liver tumor response to transarterial chemoembolization: Post-hoc analysis of a prospective clinical trial.
Clin Imaging
; 78: 194-200, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34022765
6.
Role of 3D quantitative tumor analysis for predicting overall survival after conventional chemoembolization of intrahepatic cholangiocarcinoma.
Sci Rep
; 11(1): 9337, 2021 04 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33927226